Novo Holdings A/S
CIK 1388325 · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.99B
Companies
44
Total Filings
141
Lifetime Open-Market Net
-$157.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COAG | 10%+ Owner | 4,180,550 | — | — | $0 | 1 | 2026-05-06 |
| AVLN | 10%+ Owner | 3,327,734 | — | — | $10.00M | 1 | 2026-05-05 |
| MPLT | 10%+ Owner | 2,733,681 | $27.75 | $75.86M | $16.20M | 1 | 2025-10-30 |
| IO Biotech, Inc. (IOBT) Delisted | 10%+ Owner | 4,354,449 | $0.05 | $209.0K | $7.66M | 5 | 2024-07-26 |
| SPRB | 10%+ Owner | 2,550,000 | $51.89 | $132.32M | $738.2K | 6 | 2024-03-25 |
| MGX | 10%+ Owner | 100,000 | $1.20 | $120.0K | $13.03M | 1 | 2024-02-15 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | 10%+ Owner | 3,522,136 | $3.02 | $10.64M | $1.24M | 9 | 2023-07-20 |
| IRON | 10%+ Owner | 1,090,772 | $67.99 | $74.16M | -$57.62M | 1 | 2023-06-28 |
| OnKure Therapeutics, Inc. (RPHM) Delisted | 10%+ Owner | 3,330,337 | $18.20 | $60.61M | $9.29M | 2 | 2023-06-23 |
| EWTX | 10%+ Owner | 6,071,703 | $34.83 | $211.48M | $15.00M | 2 | 2022-09-16 |
| BOLT | 10%+ Owner | 3,703,991 | $4.56 | $16.89M | $6.40M | 2 | 2022-07-15 |
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | 10%+ Owner | 2,162,290 | $10.50 | $22.70M | $7.48M | 2 | 2022-02-25 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 3,183,545 | $115.07 | $366.33M | $12.50M | 1 | 2022-02-09 |
| UTRS | 10%+ Owner | 884,484 | $0.00 | $88 | $6.96M | 1 | 2021-10-27 |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 793,265 | $11.13 | $8.83M | $6.65M | 1 | 2021-06-22 |
| INGN | 10%+ Owner | 2,079,320 | $6.40 | $13.31M | -$129.87M | 5 | 2021-06-03 |
| Galera Therapeutics, Inc. (GRTX) Delisted | 10%+ Owner | 2,459,021 | $0.14 | $356.6K | -$4.24M | 3 | 2021-02-19 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,194,379 | $4.00 | $8.78M | -$1.88M | 2 | 2021-02-01 |
| Damora Therapeutics, Inc. (GLTO) Delisted | 10%+ Owner | 2,164,458 | $28.69 | $62.10M | $5.00M | 1 | 2020-11-04 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 887,071 | $2.57 | $2.28M | $2.70M | 1 | 2020-10-22 |
| ALGS | 10%+ Owner | 2,414,563 | $5.28 | $12.75M | $3.00M | 1 | 2020-10-22 |
| PRAX | 10%+ Owner | 2,442,080 | $266.58 | $651.01M | $0 | 1 | 2020-10-21 |
| HRMY | 10%+ Owner | 3,754,973 | $34.46 | $129.40M | $3.18M | 2 | 2020-09-04 |
| NKTX | 10%+ Owner | 2,793,865 | $2.86 | $7.99M | $10.00M | 1 | 2020-07-16 |
| CRVS | 10%+ Owner | 1,389,498 | $11.93 | $16.58M | $6.67M | 6 | 2020-07-09 |
| MIST | 10%+ Owner | 2,434,470 | $1.27 | $3.09M | $1.16M | 2 | 2019-11-27 |
| MIRM | 10%+ Owner | 1,870,147 | $99.34 | $185.79M | $8.62M | 1 | 2019-07-23 |
| Morphic Holding, Inc. (MORF) Delisted | 10%+ Owner | 1,978,779 | $56.99 | $112.77M | $10.00M | 1 | 2019-07-01 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | 10%+ Owner | 1,092,008 | $2.19 | $2.39M | $16.35M | 1 | 2018-10-01 |
| KALV | 10%+ Owner | 1,726,481 | $27.00 | $46.61M | -$28.82M | 3 | 2017-10-12 |
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | 10%+ Owner | 1,102,651 | $0.48 | $529.3K | $2.86M | 3 | 2017-08-25 |
| ANAB | 10%+ Owner | 1,936,604 | $56.07 | $108.59M | -$22.57M | 5 | 2017-08-21 |
| Apollo Endosurgery, Inc. (APEN) Delisted | 10%+ Owner | 1,301,842 | $10.00 | $13.02M | -$936.5K | 2 | 2017-07-26 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | 10%+ Owner | 642,405 | $172.36 | $110.72M | -$1.53M | 6 | 2017-06-23 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 0 | — | — | -$163.30M | 6 | 2016-12-16 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 924,970 | — | — | $3.20M | 1 | 2016-11-02 |
| IRTC | 10%+ Owner | 2,124,448 | $113.65 | $241.44M | $1.70M | 1 | 2016-10-26 |
| CoLucid Pharmaceuticals, Inc. (CLCD) Delisted | 10%+ Owner | 3,156,563 | — | — | $15.00M | 2 | 2016-09-13 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | 10%+ Owner | 1,905,789 | — | — | $755.7K | 7 | 2016-07-13 |
| FLXN | 10%+ Owner | 2,247,431 | $25.05 | $56.31M | $14.41M | 3 | 2015-06-22 |
| NEVRO CORP (NVRO) Delisted | 10%+ Owner | 2,194,841 | $5.84 | $12.82M | $3.87M | 1 | 2014-11-13 |
| OTONOMY, INC. (OTIC) Delisted | 10%+ Owner | 2,175,025 | $0.08 | $167.5K | $2.99M | 2 | 2014-08-21 |
| AKBA | 10%+ Owner | 1,516,387 | $0.92 | $1.40M | $3.10M | 1 | 2014-03-26 |
| BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted | 10%+ Owner | 4,720,065 | — | — | $26.02M | 33 | 2010-07-19 |
Recent Filings · Page 3 of 15
141 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-21 | SPRB | Buy (P) | +2,208,000 | $7.00M | EDGAR |
| 2022-09-16 | EWTX | Buy (P) | +484,496 | $5.00M | EDGAR |
| 2022-07-22 | Cyteir Therapeutics, Inc. (CYT) Delisted | Sell (S) | −900,000 | -$2.70M | EDGAR |
| 2022-07-15 | BOLT | Sell (S) | −800,000 | -$1.60M | EDGAR |
| 2022-02-25 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Sell (S) | −8,110 | -$23.1K | EDGAR |
| 2022-02-09 | Arcellx, Inc. (ACLX) Delisted | Mixed | +4,016,878 | $12.50M | EDGAR |
| 2021-11-10 | IO Biotech, Inc. (IOBT) Delisted | Mixed | +3,277,932 | $4.55M | EDGAR |
| 2021-10-27 | UTRS | Mixed | +2,057,132 | $6.96M | EDGAR |
| 2021-06-23 | Cyteir Therapeutics, Inc. (CYT) Delisted | Mixed | +4,840,413 | $5.00M | EDGAR |
| 2021-06-22 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +793,265 | $6.65M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.